Trevi Therapeutics
TRVI
#7503
Rank
A$0.53 B
Marketcap
$6.00
Share price
-0.53%
Change (1 day)
193.49%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$65.84 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$45.84 Million a decrease over its 2022 earnings that were of -A$44.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$65.84 Million43.65%
2023 -A$45.84 Million2.43%
2022 -A$44.75 Million-14.45%
2021 -A$52.31 Million1.36%
2020 -A$51.61 Million23.64%
2019 -A$41.74 Million27.54%
2018 -A$32.73 Million